News

The MRFF Consumer Reference Panel’s (CRP) Principles for consumer involvement in research funded by the Medical Research Future Fund (MRFF) are now available.

We have published a set of performance indicators for assessing the success and impact of the Medical Research Future Fund (MRFF).

Professor Dianne Nicol is passionate about talking to the community about ethical, legal and social issues in genetics research. We asked Dianne about becoming an expert in this field and the most urgent issues in genetics research today.

The Australian Government is investing $382 million in nearly 200 medical research projects, including $32 million to improve First Nations health. Funding is from the Medical Research Future Fund (MRFF).

The Australian Government is investing $15 million for mitochondrial disease research. Funding is from the Medical Research Future Fund (MRFF).

Gene editing allows us to modify our genes. This can cure diseases. But it could also be used in the future to select for traits that give social or competitive advantages. Professor Nicol asked a citizens’ jury to decide under what circumstances we should allow human gene editing.

You can now read about Medical Research Future Fund (MRFF) grant opportunities forecast to open from April 2023.

It’s easy to forget about cancer screening. But detecting cancer early saves lives. Learn more about cancer screening programs and how to enter the Beautiful Shawl competition.

Everyone feels down sometimes, but if it’s constant you may want support. Learn some ways to keep yourself strong and how to reach out for help.

From 1 January 2023, the maximum price of most PBS medicines for non-concessional patients was reduced from $42.50 to $30. Don’t delay buying your PBS Medicines.

The Australian Government will invest $26 million in health and medical research to improve treatment and care for LGBTIQA+ people. Funding is from the Medical Research Future Fund (MRFF).

Researchers can apply for funding under the 2023 International Clinical Trial Collaborations grant opportunity. Funding is from the Medical Research Future Fund (MRFF).

Vaccination against influenza (flu) continues to be important this year. Vaccination is our best defence against flu viruses.

The Australian Government has responded to the Halton review into COVID-19 vaccine and treatment procurement.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

In 2018 Scott Griffiths developed a deadly rare blood cancer in his brain. He believed he was going to die. But a new precision medicine developed by his doctor Professor Maher Gandhi cured Scott. Maher is conducting a clinical trial to test if his new treatment works for other patients.

Over 90% of childhood brain cancer survivors develop life threatening and disabling health conditions after they finish cancer treatment. Engage is a consumer co-designed telehealth trial that helps these survivors manage their health and improve their quality of life.

We invite all research administration officers (RAOs) to join our next Medical Research Future Fund (MRFF) RAO Webinar at 2:00pm (AEDT) on 30 March 2023.

We invite you to join our next Medical Research Future Fund (MRFF) Webinar at 2:00pm (AEDT) on 15 March 2023.

Researchers can apply for funding under the 2023 Global Health grant opportunity from 27 March 2023. Funding is from the Medical Research Future Fund (MRFF).

Medical Research Future Fund (MRFF) grant opportunities to the value of $310.3 million are now available.

It takes time and money to turn a scientific discovery into a medical product ready for use. To help medical researchers along this road, in 2017 the MRFF began funding medical research commercialisation. The Big Picture asks what impact our funds are having.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. These recommendations replace previous ATAGI COVID-19 vaccine booster advice.

From 6 February 2023 the human papillomavirus (HPV) vaccine schedule will become a single dose schedule. Catch-up under the National Immunisation Program (NIP) will also be extended to all Australians 25 years and under.